Table 2 The relative contents of 45 identified cis-diol-containing compounds in urines of 3 types of cancer patients over healthy controls
Content ratios (vs Healthy controls) | ||||
---|---|---|---|---|
Identified cis-diol-containing compounds | Lung cancer | Colorectal cancer | Nasopharyngeal cancer | |
1 | 5-Methyluridine | 0.69 ± 0.03 | 0.52 ± 0.06 | 0.53 ± 0.04 |
2 | 6-Methyluridine | 0.81 ± 0.07 | 0.40 ± 0.05 | 0.42 ± 0.04 |
3 | Adenosine | 0.99 ± 0.13 | 1.07 ± 0.02 | 1.28 ± 0.07 |
4 | 1-Methylguanosine | 1.16 ± 0.01 | 1.40 ± 0.14 | 1.58 ± 0.07 |
5 | Guanosine | 2.08 ± 0.04 | 0.89 ± 0.00 | 1.98 ± 0.22 |
6 | 1-Methylinosine | 1.80 ± 0.16 | 1.41 ± 0.10 | 1.92 ± 0.06 |
7 | 1-Methyladenosine | 0.74 ± 0.05 | 3.77 ± 0.29 | 0.94 ± 0.07 |
8 | N2-methylguanosine | 1.33 ± 0.16 | 1.38 ± 0.09 | 1.43 ± 0.09 |
9 | N2, N2-dimethylguanosine | 1.32 ± 0.09 | 1.23 ± 0.16 | 1.57 ± 0.10 |
10 | 3-Methyluridine | 0.72 ± 0.05 | 0.91 ± 0.15 | 1.14 ± 0.11 |
11 | 5′-Deoxy-5′-methylthioadensine | 2.04 ± 0.14 | 3.26 ± 0.32 | 2.38 ± 0.32 |
12 | Succinyladenosine | 0.89 ± 0.03 | 0.74 ± 0.08 | 0.99 ± 0.07 |
13 | N6-methyladenosine | 1.27 ± 0.06 | 1.27 ± 0.02 | 1.78 ± 0.15 |
14 | Orotidine | 0.85 ± 0.07 | 0.78 ± 0.04 | 0.83 ± 0.08 |
15 | Urate-3-ribonucleoside | 1.12 ± 0.11 | 1.21 ± 0.05 | 1.09 ± 0.12 |
16 | Nicotinamide riboside | 0.69 ± 0.04 | 1.16 ± 0.05 | 1.22 ± 0.10 |
17 | n-Ribosylhistidine | 0.81 ± 0.05 | 0.83 ± 0.05 | 0.75 ± 0.01 |
18 | Cytidine | 1.29 ± 0.13 | 1.28 ± 0.08 | 1.28 ± 0.09 |
19 | Pseudouridine | 1.37 ± 0.11 | 1.13 ± 0.04 | 1.37 ± 0.17 |
20 | Uridine | 1.06 ± 0.06 | 1.24 ± 0.06 | 1.10 ± 0.06 |
21 | 5-Carbamoylmethyluridine | 0.76 ± 0.03 | 0.72 ± 0.02 | 0.73 ± 0.06 |
22 | 6-Hydroxyl-1,6-dihydropurine ribonucleoside | 0.75 ± 0.04 | 1.52 ± 0.09 | 1.29 ± 0.05 |
23 | 1-Methyl-N2-ethylguanosine | 0.73 ± 0.10 | 0.51 ± 0.02 | 0.75 ± 0.10 |
24 | 5,6-Dihydrouridine | 0.53 ± 0.07 | 1.25 ± 0.12 | 0.75 ± 0.08 |
25 | 5-Methylcytidine | 1.26 ± 0.07 | 0.56 ± 0.04 | 0.55 ± 0.05 |
26 | Inosine | 1.27 ± 0.13 | 1.26 ± 0.11 | 1.24 ± 0.01 |
27 | Ribosylpyridinonecarboxamide | 1.44 ± 0.11 | 1.61 ± 0.09 | 1.88 ± 0.10 |
28 | Xanthosine | 1.62 ± 0.13 | 1.42 ± 0.13 | 2.14 ± 0.14 |
29 | 8-Oxo-Guanosine | 0.58 ± 0.01 | 1.25 ± 0.02 | 1.11 ± 0.05 |
30 | 3-Methylcytidine | 1.29 ± 0.16 | 2.11 ± 0.21 | 0.95 ± 0.11 |
31 | 5-Methylaminomethyluridine | 1.55 ± 0.15 | 1.05 ± 0.08 | 0.75 ± 0.09 |
32 | 5′-Deoxyadenosine | 1.06 ± 0.09 | 1.07 ± 0.14 | 0.77 ± 0.10 |
33 | 3-Hydroxychavicol 1-glucoside | 1.26 ± 0.10 | 1.31 ± 0.07 | 1.64 ± 0.12 |
34 | 5-Methylaminomethyl-2-thiouridine | 1.39 ± 0.11 | 0.48 ± 0.05 | 0.005 ± 0.00 |
35 | Uracil-5-oxyacetic acid methylester | 1.75 ± 0.04 | 1.38 ± 0.14 | 1.82 ± 0.22 |
36 | N4-acetylcytidine | 1.61 ± 0.17 | 1.56 ± 0.20 | 1.87 ± 0.17 |
37 | 1-Ribosyl-N-acetylhistamine | 2.39 ± 0.15 | 0.09 ± 0.01 | 0.16 ± 0.02 |
38 | N6-threonylcarbamoyladenosine | 0.57 ± 0.04 | 1.00 ± 0.05 | 1.11 ± 0.03 |
39 | N6-Methyl-2-methylthioadenosine | 0.98 ± 0.03 | 0.84 ± 0.07 | 1.11 ± 0.02 |
40 | 7-Methylguanosine | 2.34 ± 0.07 | 0.55 ± 0.04 | 2.05 ± 0.27 |
41 | 4-((1H-imidazol-2-yl)methyl)phenol-1-glucoside | 9.49 ± 1.19 | 0.50 ± 0.02 | 0.12 ± 0.01 |
42 | N6-isopentenyladenosine | 25.04 ± 2.18 | 1.01 ± 0.01 | 0.85 ± 0.06 |
43 | N2,N2,7-trimethylguanosine | 1.61 ± 0.15 | 1.71 ± 0.15 | 1.55 ± 0.19 |
44 | N2,7-dimethylguanosine | 0.72 ± 0.08 | 0.71 ± 0.07 | 0.90 ± 0.12 |
45 | 1-Ribosyl-N-propionylhistamine | 8.90 ± 0.97 | 1.51 ± 0.17 | 3.54 ± 0.35 |